Tilray Medical Granted Approval to Introduce Third Medical Cannabis Product in Portugal
24 juil. 2024 07h00 HE
|
Tilray Brands, Inc.
Tilray Medical receives second approval for new medical cannabis extract in Portugal: Tilray Oral Solution THC10:CBD10 or Tilray Solução Oral THC10:CBD10.
Tilray Medical Receives Approval for First Medical Cannabis Extract in Portugal
14 mars 2024 07h00 HE
|
Tilray Brands, Inc.
Tilray Medical has received approval for the first medical cannabis extract, Tilray Oral Solution THC 5 CBD 20, in Portugal.
Tilray Medical Expands Commercial Footprint in Europe and Broadens Distribution Across the Czech Republic
06 avr. 2023 08h45 HE
|
Tilray Brands, Inc.
COLOGNE, Germany, April 06, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and empowering the worldwide community to live their...
Tilray Medical Relaunches Cannabis Oral Solution Across Ireland
04 oct. 2022 07h00 HE
|
Tilray Brands, Inc.
LEAMINGTON, Ontario and CANTANHEDE, Portugal, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring...
Tilray Medical Receives Approval to Extend Market Authorization in Italy
22 sept. 2022 07h00 HE
|
Tilray Brands, Inc.
LEAMINGTON, Ontario and CANTANHEDE, Portugal, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company...
Tilray Initiates Roundtable With German Regulators to Kick-Off Draft Legislation to Legalize Adult-Use Cannabis in Germany
06 sept. 2022 09h00 HE
|
Tilray Brands, Inc.
BERLIN, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today announced...
Tilray Medical Bolsters Market Leading Position in Europe With Market Authorization in Poland
17 août 2022 07h00 HE
|
Tilray Brands, Inc.
LEAMINGTON, Ontario and CANTANHEDE, Portugal, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and...
Tilray Medical Launches Cannabis Education Platform ‘WeCare-MedicalCannabis’ Across Europe
19 juil. 2022 07h00 HE
|
Tilray Brands, Inc.
NEUMÜNSTER, Germany, July 19, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods...
Tilray Medical Expands Portfolio of Medical Cannabis Products in the UK
29 juin 2022 07h00 HE
|
Tilray Brands, Inc.
LEAMINGTON, Ontario, June 29, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods...